Objective To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …

A sizable proportion of coronary artery disease (CAD) patients undergoing percutaneous
coronary intervention (PCI) with stent implantation have an indication for treatment with oral …

Background To compare the efficacy and safety of edoxaban vs warfarin in high-risk
subgroups. Methods ENGAGE AF-TIMI 48 was a multicenter randomized, double-blind …

Background and purpose Real-world data about treatment convenience and satisfaction in
Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K …

Background Patients with mechanical heart valves are still not eligible for treatment with
direct oral anticoagulants (DOAC). We aimed to conduct a proof-of-principle study …

Objectives: We aimed to analyze the characteristics and mechanisms of acute ischemic
stroke (AIS) in patients with nonvalvular atrial fibrillation (NVAF) who received prior …

Background Despite the widespread and increasing use of NOACs in Saudi Arabia, there is
a lack of contemporary guidance specific to the region. In particular, guidance on NOAC use …

A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial
fibrillation, successfully treated with bypassing agents - Giuffrida - 2021 - Clinical Case Reports …

Aim To evaluate the efficacy (rate of recanalization) of therapy with novel oral anticoagulants
(NOAC; rivaroxaban, apixaban) compared to conventional treatment (low molecular weight …

Cilj istraživanja: Cilj istraživanja bio je prikazati demografske karakteristike bolesnika na
kroničnoj hemodijalizi i utvrditi prevalenciju fibrilacije/undulacije atrija uz prikaz odabira …